肾盂输尿管癌诊治及预后分析(附68例报告)  

Diagnosis treatment and prognostic analysis of renal pelvic and ureteral cancer (report of 68 cases)

作　　者：王斌[1] 何中舟[2] 宋希双[1] 高春章[1] 

机构地区：[1]大连医科大学第一临床学院泌尿外科,辽宁大连116011 [2]大连大学附属医院泌尿外科,辽宁大连116011

出　　处：《中国现代医学杂志》2005年第21期3285-3286,共2页China Journal of Modern Medicine

摘　　要：目的探讨肾盂输尿管癌的诊治方法及其预后。方法回顾性总结68例经病理证实的肾盂输尿管癌,对诊治中若干问题进行探讨分析。结果肉眼血尿、腰痛和肾积水是本病三大临床表现。CT和尿细胞学检查的阳性率是92%和33%,46例随访,5a生存率80%。结论尿脱落细胞是较好的定性诊断方法,CT检查是重要定位诊断方法,肾输尿管及膀胱袖状切除术仍是主要的治疗方法。病人的预后与肿瘤部位、临床分期、病理分级及DNA的倍体类型有关。[Objective] To probe into the diagnosis treatment and prognostic of renal pelvic and ureteral cancer. [Methods] Cases of renal pelvic and ureteral cancer treated in the last five years were reviewed, Several aspects of the diagnosis and treatment were probed into. [Results] Hematuria flank pain and hydronephrosis were the main presentations of these patients. CT scanning and urine cytology were 92% and 33%. The patients have been followed-up for the 5 years. Survival rate was 80%. [Conclusions] CT is very important for location in renal pelvic and ureteral cancer while urine cytology is wseful. Nephrowreterectomy with excision of bladder cuff was the treatment of choice. The prognosis was relevant to the stage grade and DNA content of renal pelvic and ureteral cancer.

关 键 词：肾孟输尿管癌 诊断 治疗 预后 

分 类 号：R737.11[医药卫生—肿瘤]